Biography

David Pyott, MD (Hon), is an accomplished international pharmaceutical executive with more than 30 years of leadership and management experience with particular expertise in organizational scaling.

Most recently, he served as Chairman and Chief Executive Officer of Allergan, Inc. where, for more than 17 years in this role, he transformed the company from a focused eye care business with $1 billion in annual sales into a global specialty pharmaceutical and medical device company with annual sales of more than $7 billion. Before that, David served as Head of the Novartis Nutrition Division and served as a member of the Executive Committee of Novartis AG.

In addition to Tarsus, Mr. Pyott currently serves as a member of the Board of Directors of Alnylam Pharmaceuticals and Pliant Therapeutics. He was previously a member of the Supervisory Board of Royal Philips in the Netherlands, a public diversified health technology company, and a member of the Board of Directors of BioMarin Pharmaceutical Inc.

Mr. Pyott is also Chairman of the Governing Board of the London Business School, Vice President and co-Founder of the Ophthalmology Foundation, and a Trustee of the California Institute of Technology.

Mr. Pyott holds a Diploma in International and European Law from the Europa Institute at the University of Amsterdam, an Honorary Degree in Medicine and a Master of Arts degree from the University of Edinburgh, and a Master of Business Administration degree from the London Business School.